Risk Management and Healthcare Policy

SJR Rank #8,607H-index: 58SJR: 0.675Best quartile: Q2Open AccessAPC: US$2,836Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Dove Medical Press Ltd

Country

New Zealand

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Health PolicyQ2
  • Public Health, Environmental and Occupational HealthQ2

Areas: Medicine

Most published research topics

COVID-19 and Mental HealthHealthcare Systems and ReformsGlobal Maternal and Child HealthVaccine Coverage and HesitancyPatient Safety and Medication ErrorsCOVID-19 epidemiological studiesHealthcare Policy and ManagementHealthcare professionals’ stress and burnoutInfection Control in HealthcareInfection Control and Ventilation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025080160240320

Detailed Information

ISSN

1179-1594

SJR Best Quartile

Q2

Region

Pacific Region

Citations per Document (2 years)

2.65

References per Document

40.19

Coverage

2009-2026

Scope

Risk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of public health, policy and preventative measures to promote good health and improve morbidity and mortality in the population. Specific topics covered in the journal include: Public and community health Policy and law Preventative and predictive healthcare Risk and hazard management Epidemiology, detection and screening Lifestyle and diet modification Vaccination and disease transmission/modification programs Health and safety and occupational health Healthcare services provision Health literacy and education Advertising and promotion of health issues Health economic evaluations and resource management Risk Management and Healthcare Policy focuses on human interventional and observational research. The journal welcomes submitted papers covering original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. Case reports will only be considered if they make a valuable and original contribution to the literature. The journal does not accept study protocols, animal-based or cell line-based studies.

Metrics from SCImago Journal Rank 2025. View on SCImago